Molex Ayus is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Dki Jakarta. The company was founded in 1985. Molex Ayus, a prominent player in the pharmaceutical industry, was founded by a group of visionary entrepreneurs dedicated to advancing healthcare solutions. The company focuses on the development and manufacturing of high-quality pharmaceutical products, with a primary emphasis on prescription medications and over-the-counter drugs. Molex Ayus has expanded its operations significantly since its inception, establishing a robust presence across Indonesia with multiple branches and distribution centers. The company's product portfolio includes a wide range of therapeutic categories, such as cardiovascular, anti-infective, and gastrointestinal medications. Molex Ayus is known for its flagship brands, which have gained trust among healthcare professionals and patients alike. The company is committed to research and development, continuously investing in innovative solutions to address unmet medical needs. Globally, Molex Ayus has extended its reach to several countries in Southeast Asia, enhancing its international footprint through strategic partnerships and collaborations with local pharmaceutical firms. The company is a member of various industry associations, actively participating in initiatives to promote healthcare advancements and regulatory compliance. Molex Ayus is dedicated to sustainable practices and corporate social responsibility, aiming to improve access to essential medicines while minimizing environmental impact. The company's mission is to enhance the quality of life through innovative healthcare solutions, guided by its vision to be a leader in the pharmaceutical industry, delivering excellence and reliability in every product.
Headquarters
Kota Jakarta Pusat Kebon Kelapa Gambir Dki Jakarta
Central Jakarta; Jakarta;
Postal Code: 10120
Contact Details: Purchase the PT Molex Ayus report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service